IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 171 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,226,570 | -23.2% | 489,356 | +18.9% | 0.00% | 0.0% |
| Q2 2023 | $2,898,058 | +85.6% | 411,656 | +61.1% | 0.00% | +100.0% |
| Q1 2023 | $1,561,447 | -14.5% | 255,556 | -10.6% | 0.00% | 0.0% |
| Q4 2022 | $1,825,981 | -31.8% | 285,756 | +2.2% | 0.00% | -50.0% |
| Q3 2022 | $2,678,000 | -12.6% | 279,556 | +0.7% | 0.00% | 0.0% |
| Q2 2022 | $3,064,000 | -38.0% | 277,556 | -6.5% | 0.00% | -33.3% |
| Q1 2022 | $4,941,000 | -5.1% | 296,756 | +8.8% | 0.00% | 0.0% |
| Q4 2021 | $5,209,000 | -21.8% | 272,856 | +1.0% | 0.00% | -25.0% |
| Q3 2021 | $6,662,000 | -1.2% | 270,156 | +4.2% | 0.00% | 0.0% |
| Q2 2021 | $6,743,000 | -15.3% | 259,156 | +3.1% | 0.00% | -20.0% |
| Q1 2021 | $7,958,000 | -30.9% | 251,356 | +1.2% | 0.01% | -37.5% |
| Q4 2020 | $11,524,000 | +43.5% | 248,356 | +1.8% | 0.01% | +33.3% |
| Q3 2020 | $8,028,000 | +21.8% | 243,856 | +1.5% | 0.01% | 0.0% |
| Q2 2020 | $6,592,000 | +5.9% | 240,156 | +15.5% | 0.01% | -14.3% |
| Q1 2020 | $6,226,000 | +11.6% | 208,000 | +3.2% | 0.01% | +16.7% |
| Q4 2019 | $5,578,000 | +55.5% | 201,500 | +2.2% | 0.01% | +50.0% |
| Q3 2019 | $3,587,000 | -25.1% | 197,100 | +1.0% | 0.00% | -20.0% |
| Q2 2019 | $4,786,000 | +163.7% | 195,200 | +2.3% | 0.01% | +150.0% |
| Q1 2019 | $1,815,000 | +16.0% | 190,800 | +8.0% | 0.00% | 0.0% |
| Q4 2018 | $1,564,000 | +12.4% | 176,700 | +43.0% | 0.00% | 0.0% |
| Q3 2018 | $1,391,000 | -12.1% | 123,600 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,582,000 | -24.3% | 123,600 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $2,089,000 | +149.6% | 123,600 | +18.2% | 0.00% | +200.0% |
| Q4 2017 | $837,000 | +3.2% | 104,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $811,000 | +23.8% | 104,600 | +17.4% | 0.00% | 0.0% |
| Q2 2017 | $655,000 | – | 89,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |